Parallel Advisors’s Vir Biotechnology VIR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.36K | Sell |
468
-44
| -9% | -$222 | ﹤0.01% | 2973 |
|
|
2025
Q1 | $3.32K | Hold |
512
| – | – | ﹤0.01% | 2806 |
|
|
2024
Q4 | $3.76K | Hold |
512
| – | – | ﹤0.01% | 2721 |
|
|
2024
Q3 | $3.84K | Sell |
512
-265
| -34% | -$1.99K | ﹤0.01% | 2693 |
|
|
2024
Q2 | $6.92K | Sell |
777
-74
| -9% | -$659 | ﹤0.01% | 2425 |
|
|
2024
Q1 | $8.62K | Hold |
851
| – | – | ﹤0.01% | 2368 |
|
|
2023
Q4 | $8.56K | Buy |
851
+352
| +71% | +$3.54K | ﹤0.01% | 2347 |
|
|
2023
Q3 | $4.68K | Sell |
499
-5
| -1% | -$47 | ﹤0.01% | 2520 |
|
|
2023
Q2 | $12.4K | Sell |
504
-73
| -13% | -$1.79K | ﹤0.01% | 2084 |
|
|
2023
Q1 | $13.4K | Buy |
577
+567
| +5,670% | +$13.2K | ﹤0.01% | 2015 |
|
|
2022
Q4 | $253 | Sell |
10
-7
| -41% | -$177 | ﹤0.01% | 3155 |
|
|
2022
Q3 | $0 | Sell |
17
-6
| -26% | – | ﹤0.01% | 3514 |
|
|
2022
Q2 | $1K | Buy |
23
+13
| +130% | +$565 | ﹤0.01% | 2859 |
|
|
2022
Q1 | $0 | Sell |
10
-44
| -81% | – | ﹤0.01% | 3293 |
|
|
2021
Q4 | $2K | Sell |
54
-20,725
| -100% | -$768K | ﹤0.01% | 2761 |
|
|
2021
Q3 | $904K | Sell |
20,779
-10,383
| -33% | -$452K | 0.04% | 272 |
|
|
2021
Q2 | $1.47M | Buy |
31,162
+22,364
| +254% | +$1.06M | 0.06% | 197 |
|
|
2021
Q1 | $451K | Sell |
8,798
-4,787
| -35% | -$245K | 0.02% | 371 |
|
|
2020
Q4 | $364K | Hold |
13,585
| – | – | 0.02% | 397 |
|
|
2020
Q3 | $466K | Buy |
13,585
+12,528
| +1,185% | +$430K | 0.03% | 322 |
|
|
2020
Q2 | $43K | Buy |
+1,057
| New | +$43K | ﹤0.01% | 1107 |
|